These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

305 related articles for article (PubMed ID: 32848737)

  • 1. Hyaluronic Acid-Mediated Drug Delivery System Targeting for Inflammatory Skin Diseases: A Mini Review.
    How KN; Yap WH; Lim CLH; Goh BH; Lai ZW
    Front Pharmacol; 2020; 11():1105. PubMed ID: 32848737
    [TBL] [Abstract][Full Text] [Related]  

  • 2. CD44 Assists the Topical Anti-Psoriatic Efficacy of Curcumin-Loaded Hyaluronan-Modified Ethosomes: A New Strategy for Clustering Drug in Inflammatory Skin.
    Zhang Y; Xia Q; Li Y; He Z; Li Z; Guo T; Wu Z; Feng N
    Theranostics; 2019; 9(1):48-64. PubMed ID: 30662553
    [No Abstract]   [Full Text] [Related]  

  • 3. Topical Delivery of ROS-Responsive Methotrexate Prodrug Nanoassemblies by a Dissolvable Microneedle Patch for Psoriasis Therapy.
    Zhou Y; Yang L; Lyu Y; Wu D; Zhu Y; Li J; Jiang D; Xin X; Yin L
    Int J Nanomedicine; 2023; 18():899-915. PubMed ID: 36824414
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hyaluronic acid decorated tacrolimus-loaded nanoparticles: Efficient approach to maximize dermal targeting and anti-dermatitis efficacy.
    Zhuo F; Abourehab MAS; Hussain Z
    Carbohydr Polym; 2018 Oct; 197():478-489. PubMed ID: 30007638
    [TBL] [Abstract][Full Text] [Related]  

  • 5. CD44 targeted indirubin nanocrystal-loaded hyaluronic acid hydrogel for the treatment of psoriasis.
    Li L; Liu C; Fu J; Wang Y; Yang D; Peng B; Liu X; Han X; Meng Y; Feng F; Hu X; Qi C; Wang Y; Zheng Y; Li P
    Int J Biol Macromol; 2023 Jul; 243():125239. PubMed ID: 37295696
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Applications and delivery mechanisms of hyaluronic acid used for topical/transdermal delivery - A review.
    Zhu J; Tang X; Jia Y; Ho CT; Huang Q
    Int J Pharm; 2020 Mar; 578():119127. PubMed ID: 32036009
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hyaluronic acid-modified betamethasone encapsulated polymeric nanoparticles: fabrication, characterisation, in vitro release kinetics, and dermal targeting.
    Pandey M; Choudhury H; Gunasegaran TAP; Nathan SS; Md S; Gorain B; Tripathy M; Hussain Z
    Drug Deliv Transl Res; 2019 Apr; 9(2):520-533. PubMed ID: 29488170
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hyaluronic acid-containing ethosomes as a potential carrier for transdermal drug delivery.
    Xie J; Ji Y; Xue W; Ma D; Hu Y
    Colloids Surf B Biointerfaces; 2018 Dec; 172():323-329. PubMed ID: 30176512
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hyaluronic acid and HA-modified cationic liposomes for promoting skin penetration and retention.
    Ni C; Zhang Z; Wang Y; Zhang Z; Guo X; Lv H
    J Control Release; 2023 May; 357():432-443. PubMed ID: 37004799
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hyaluronic Acid-Based Dissolving Microneedle Patch Loaded with Methotrexate for Improved Treatment of Psoriasis.
    Du H; Liu P; Zhu J; Lan J; Li Y; Zhang L; Zhu J; Tao J
    ACS Appl Mater Interfaces; 2019 Nov; 11(46):43588-43598. PubMed ID: 31651148
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Skin-penetrating polymeric nanoparticles incorporated in silk fibroin hydrogel for topical delivery of curcumin to improve its therapeutic effect on psoriasis mouse model.
    Mao KL; Fan ZL; Yuan JD; Chen PP; Yang JJ; Xu J; ZhuGe DL; Jin BH; Zhu QY; Shen BX; Sohawon Y; Zhao YZ; Xu HL
    Colloids Surf B Biointerfaces; 2017 Dec; 160():704-714. PubMed ID: 29035818
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of ethosomes and liposomes for skin delivery of psoralen for psoriasis therapy.
    Zhang YT; Shen LN; Wu ZH; Zhao JH; Feng NP
    Int J Pharm; 2014 Aug; 471(1-2):449-52. PubMed ID: 24907596
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Methotrexate-loaded hyaluronan-modified liposomes integrated into dissolving microneedles for the treatment of psoriasis.
    Shen S; Zheng X; Dong X; Fang M; Wan A; Zhu T; Yang Q; Xie J; Yan Q
    Eur J Pharm Sci; 2024 Apr; 195():106711. PubMed ID: 38290610
    [TBL] [Abstract][Full Text] [Related]  

  • 14. An inflammation-responsive double-layer microneedle patch for recurrent atopic dermatitis therapy.
    Song L; Chi J; Li Z; Tao Y; Sun Y; Zhou Q; Lu S; Huang Q; Huang S; Lu X; Wu M; Yang Y; Chen L; Li X; Shi K; Xiao J
    Int J Pharm; 2023 Aug; 643():123215. PubMed ID: 37460048
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dermal and transdermal delivery of an anti-psoriatic agent via ethanolic liposomes.
    Dubey V; Mishra D; Dutta T; Nahar M; Saraf DK; Jain NK
    J Control Release; 2007 Nov; 123(2):148-54. PubMed ID: 17884226
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Enhanced topical penetration, system exposure and anti-psoriasis activity of two particle-sized, curcumin-loaded PLGA nanoparticles in hydrogel.
    Sun L; Liu Z; Wang L; Cun D; Tong HHY; Yan R; Chen X; Wang R; Zheng Y
    J Control Release; 2017 May; 254():44-54. PubMed ID: 28344018
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hyaluronic acid engineered gallic acid embedded chitosan nanoparticle as an effective delivery system for treatment of psoriasis.
    Sheikh A; Hazari SA; Molugulu N; Alshehri SA; Wahab S; Sahebkar A; Kesharwani P
    Environ Res; 2023 Dec; 238(Pt 1):117086. PubMed ID: 37683783
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Topical hyaluronidase decreases hyaluronic acid and CD44 in human skin and in reconstituted human epidermis: evidence that hyaluronidase can permeate the stratum corneum.
    Laugier JP; Shuster S; Rosdy M; Csóka AB; Stern R; Maibach HI
    Br J Dermatol; 2000 Feb; 142(2):226-33. PubMed ID: 10730753
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Rationalizing the Design of Hyaluronic Acid-Decorated Liposomes for Targeting Epidermal Layers: A Combination of Molecular Dynamics and Experimental Evidence.
    Franzé S; Rama F; Rocco P; Debernardi M; Bincoletto V; Arpicco S; Cilurzo F
    Mol Pharm; 2021 Nov; 18(11):3979-3989. PubMed ID: 34570510
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hyaluronic Acid Nanoparticles as a Topical Agent for Treating Psoriasis.
    Lee WH; Rho JG; Yang Y; Lee S; Kweon S; Kim HM; Yoon J; Choi H; Lee E; Kim SH; You S; Song Y; Oh YS; Kim H; Han HS; Han JH; Jung M; Park YH; Choi YS; Han S; Lee J; Choi S; Kim JW; Park JH; Lee EK; Song WK; Kim E; Kim W
    ACS Nano; 2022 Dec; 16(12):20057-20074. PubMed ID: 36373736
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.